Literature DB >> 1149753

Motor lesions in herpes zoster. Incidence and special features.

S Weiss, M Streifler, H J Weiser.   

Abstract

In the review of 117 patients hospitalized for herpes zoster (HZ) during the 10-year-period of 1960-1969, six patients with motor paralysis of the limbs were found. The incidence of motor paralysis in HZ which ranges in the literature between 0.5 and 31%, was 18% in our series. Reasons for these differences are discussed. An uncommon feature, local recurrence of HZ with motor deficit pertaining to the same segments is reported, and joint subluxation, a rare complication of motor HZ, is also described. The importance of looking for diaphragmatic paralysis and motor deficit in the thoracoabdominal segments, not readily revealed in routine examination, is stressed.

Entities:  

Mesh:

Year:  1975        PMID: 1149753     DOI: 10.1159/000114687

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

1.  Focal weakness following herpes zoster.

Authors:  O C Cockerell; I E Ormerod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

2.  Hemichorea associated with varicella-zoster reinfection and endocarditis. A case report.

Authors:  K P Hammann; B Henkel; R Erbel; G Krämer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

3.  Parsonage-Turner Syndrome rather than Zoster Neuritis?

Authors:  Karim Gariani; Michel R Magistris; Mathieu R Nendaz
Journal:  Case Rep Neurol       Date:  2011-07-21

4.  Temporary unilateral abdominal muscle paralysis due to herpes zoster without typical vesicles or pain.

Authors:  Hitoshi Eguchi; Naoko Furukawa; Masaki Tago; Motoshi Fujiwara; Akihiko Ogushi; Jun Tokutomi; Seungeon Choi; Kenichi Yamamoto; Kojiro Yoshihara; Shu-Ichi Yamashita
Journal:  J Gen Fam Med       Date:  2017-03-21

5.  Monoparesis secondary to herpes zoster.

Authors:  S Bilal; M Iqbal; B O'Moore; J Alam; A Suliman
Journal:  Ir J Med Sci       Date:  2009-08-27       Impact factor: 2.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.